Lynn Shapiro Snyder, Senior Member of the Firm in the Health Care & Life Sciences and Litigation practices, in the firm’s Washington, DC, office, was quoted in Barron’s, in “Humana Stock Can Rise Above the Health-Care Fray,” by Josh Nathan-Kazis. (Read the full version – subscription required.)
Following is an excerpt:
In April, when Bernie Sanders proposed a bill in the Senate that would do away with private health insurance, investors fled managed-care stocks. Over the following week, the S&P 500 Managed Health Care index, which tracks health-insurance companies, dropped 13.5%.
Now, as cooler heads prevail, one stock that investors should look at is Humana (ticker: HUM), a managed-care company well-positioned to ride out health-reform jitters. And for the long-term investor looking toward 2021 and beyond, there are tantalizing scenarios under a Democratic administration that could allow Humana to win big. …
While the proposal from Sanders has grabbed attention, experts doubt that any new health law could do away with the role that managed-care companies play in the Medicare ecosystem.
“We have spent 50 years putting managed-care bells and whistles on top of the original Medicare,” says Lynn Shapiro Snyder, a lawyer at Epstein Becker Green who specializes in health-care law and health policy. “I think there will be a role for managed-care companies in any type of government expansions.”